Advertisement
Screener

C4 Therapeutics, Inc. (CCCC) Net Margin

C4 Therapeutics, Inc. (CCCC) Net Margin

  • 2026-06-30: Net Margin -355.90%.
  • 2026-03-31: Net Margin -408.47%.
  • 2025-12-31: Net Margin -185.97%.
  • 2025-09-30: Net Margin -286.43%.

Complete source-backed net margin history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-355.90%
2026-03-31-408.47%
2025-12-31-185.97%
2025-09-30-286.43%
2025-06-30-402.60%
2025-03-31-363.66%
2024-12-31-667.82%
2024-09-30-160.57%
2024-06-30-147.56%
2024-03-31-933.23%
2023-12-31-1065.75%
2023-09-30-244.19%
2023-06-30-1348.42%
2023-03-31-925.25%
2022-12-31-1302.91%
2022-09-30-473.17%
2022-06-30-198.15%
2022-03-31-413.12%
2021-12-31-77.99%
2021-09-30-290.39%
2021-06-30-230.86%

Annual Net Margin

DateNet Margin
2025-12-31-292.08%
2024-12-31-295.96%
2023-12-31-638.34%
2022-12-31-412.19%
2021-12-31-183.23%

Similar stocks

Stock NameCountryMarket CapPE Ratio
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60